CXCL9 and osteosarcoma: Furthermore, our work demonstrated that pharmacological inhibition of c-Myc in osteosarcoma can promote T cell trafficking into tumor beds by increasing the expression and secretion of CCL5, CXCL9, and CXCL10 (Fig. 5).